SAN DIEGO--(BUSINESS WIRE)--Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company whose product ArteFill is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of “smile line” wrinkles, today announced that Dr. Stacy Smith, a leading San Diego based dermatologist, is conducting a head-to-head clinical study comparison of dermal fillers – ArteFill, Radiesse and Restylane. This 24 patient study will evaluate nasolabial fold, or smile line wrinkle, correction over a two year period.
